Sign in

Dr Reddy’s to get freezers from Rockwell to store Sputnik V

Dr Reddy’s had earlier tied up with the Russian Direct Investment Fund that markets Sputnik V globally, to distribute first 250 million doses of the vaccine.

Published on: Jun 10, 2021, 24:40:01 IST
By , Hindustan Times, New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

r Reddy’s Laboratories has entered into a strategic partnership with Hyderabad-based Rockwell Industries, specialising in commercial cold chain appliance manufacturing, to provide vaccine freezers for storing Sputnik V, the Russian-made Covid-19 vaccine, across India.

The deal has been closed to supply at least 750 Covid-19 vaccine freezers to various hospitals and institutions across the country, 500 of these being specifically for Sputnik V. (Reuters)
The deal has been closed to supply at least 750 Covid-19 vaccine freezers to various hospitals and institutions across the country, 500 of these being specifically for Sputnik V. (Reuters)

The deal has been closed to supply at least 750 Covid-19 vaccine freezers to various hospitals and institutions across the country, 500 of these being specifically for Sputnik V.

The freezer plays a critical role in the safety of vaccine and its potency. Sputnik V vaccine requires a temperature of -18°C to remain stable and potent.

Dr Reddy’s had earlier tied up with the Russian Direct Investment Fund that markets Sputnik V globally, to distribute first 250 million doses of the vaccine.

“This is a huge endorsement for our Covid-19 vaccine freezer. Our technology ensures that Sputnik V’s storage management at vaccine centres meets the stringent refrigeration standards set forth by Sputnik V manufacturers,” Ashok Gupta, managing director, Rockwell Industries Ltd, said.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.